The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565 · cited 1×
“Furthermore, nano-sized polymeric carriersencapsulated CPT have exhibited a prolonged circulation time in vivo by avoiding the reticuloendothelial system (RES), and the prolonged circulation time of the polymeric carriers allows the encapsulated CPT to extravasate and accumulate into the tumor tissue, wherein a disorg…”
BackgroundLong-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438
Wall, M. E., Wani, M. C., Cook, C. E., Palmer, K. H., McPhail, A. T., & Sim, G. A. (1966) · Journal of the American Chemical Society · doi:10.1021/ja00968a057 · Cited by 2,258
Openings Between Defective Endothelial Cells Explain Tumor Vessel Leakiness
Hashizume, H., Baluk, P., Morikawa, S., McLean, J. W., Thurston, G., Roberge, S., Jain, R. K., & McDonald, D. M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65006-7 · Cited by 1,689
Hsiang, Y. H., & Liu, L. F. (1988) · PubMed · Cited by 841
The Current Status of Camptothecin Analogues as Antitumor Agents
Slichenmyer, W. J., Rowinsky, E. K., Donehower, R. C., & Kaufmann, S. H. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.4.271 · Cited by 618
García‐Carbonero, R., & Supko, J. G. (2002) · PubMed · Cited by 498
Yang, S. C., Lu, L. F., Cai, Y., Zhu, J. B., Liang, B. W., & Yang, C. Z. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00007-3 · Cited by 476
A kinetic and Mechanistic Study of the Hydrolysis of Camptothecin and Some Analogues
Fassberg, J., & Stella, V. J. (1992) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600810718 · Cited by 464
Camptothecin: current perspectives
Thomas, C. J., Rahier, N. J., & Hecht, S. M. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2003.11.036 · Cited by 451
Camptothecin and taxol: discovery to clinic--thirteenth Bruce F. Cain Memorial Award Lecture.
Wall, M. E., & Wani, M. C. (1995) · PubMed · Cited by 376
Camptothecin and Taxol: Historic Achievements in Natural Products Research
Oberlies, N. H., & Kroll, D. J. (2004) · Journal of Natural Products · doi:10.1021/np030498t · Cited by 353
Camptothecin and taxol: Discovery to clinic
Wall, M. E. (1998) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199809)18:5<299::aid-med2>3.0.co;2-o · Cited by 330
Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel
Kim, J.-H., Kim, Y.-S., Kim, S., Park, J. H., Kim, K., Choi, K., Chung, H., Jeong, S. Y., Park, R.-W., Kim, I.-S., et al. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.12.013 · Cited by 313
Self-citationCamptothecins: from bench research to hospital wards.
Potmĕsil, M. (1994) · PubMed · Cited by 310
Morgan, M. T., Nakanishi, Y., Kroll, D. J., Griset, A. P., Carnahan, M. A., Wathier, M., Oberlies, N. H., Manikumar, G., Wani, M. C., & Grinstaff, M. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2066 · Cited by 301
Hyung Park, J., Kwon, S., Lee, M., Chung, H., Kim, J.-H., Kim, Y.-S., Park, R.-W., Kim, I.-S., Bong Seo, S., Kwon, I. C., et al. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2005.05.028 · Cited by 296
Self-citationKwon, S., Park, J. H., Chung, H., Kwon, I. C., Jeong, S. Y., & Kim, I.-S. (2003) · Langmuir · doi:10.1021/la0350608 · Cited by 269
Self-citationSon, Y. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00231-1 · Cited by 267
Camptothecin and taxol: from discovery to clinic
Wall, M. E., & Wani, M. C. (1996) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(95)01367-9 · Cited by 264
Park, K., Kim, J.-H., Nam, Y. S., Lee, S., Nam, H. Y., Kim, K., Park, J. H., Kim, I.-S., Choi, K., Kim, S. Y., et al. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.04.009 · Cited by 257
Self-citationSelf-assembled nanoparticles containing hydrophobically modified glycol chitosan for gene delivery
Sang Yoo, H., Eun Lee, J., Chung, H., Chan Kwon, I., & Young Jeong, S. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.11.033 · Cited by 212
Park, J. H., Kwon, S., Nam, J.-O., Park, R.-W., Chung, H., Seo, S. B., Kim, I.-S., Kwon, I. C., & Jeong, S. Y. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.12.020 · Cited by 190
Self-citationKim, K., Kwon, S., Park, J. H., Chung, H., Jeong, S. Y., Kwon, I. C., & Kim, I.-S. (2005) · Biomacromolecules · doi:10.1021/bm049305m · Cited by 180
Self-citationBc, G., Hinz, H. R., Kozielski, A. J., et al. (1991) · PubMed · Cited by 178
Tardi, P. G., CHOICE, E., Masin, D., Redelmeier, T. E., Bally, M. B., & Madden, T. D. (2000) · PubMed · Cited by 161
Park, J. H., Cho, Y. W., Chung, H., Kwon, I. C., & Jeong, S. Y. (2003) · Biomacromolecules · doi:10.1021/bm034094r · Cited by 158
Self-citationCamptothecin and its analogues: a review on their chemotherapeutic potential
Sriram, D., Yogeeswari, P., Thirumurugan, R., & Bal, T. R. (2005) · Natural Product Research · doi:10.1080/14786410412331299005 · Cited by 153
SHIM, W., Kim, J. H., Kim, K., KIM, Y., PARK, R., KIM, I., KWON, I., & Lee, D.-H. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.09.027 · Cited by 133
Self-citationWatanabe, M., Kawano, K., Yokoyama, M., Opanasopit, P., Okano, T., & Maitani, Y. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.030 · Cited by 128
Influence of serum and albumins from different species on stability of camptothecin-loaded micelles
Opanasopit, P., Yokoyama, M., Watanabe, M., Kawano, K., Maitani, Y., & Okano, T. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.02.014 · Cited by 120
Cho, Y. W., Park, S. A., Han, T. H., Son, D. H., Park, J. S., Oh, S. J., Moon, D. H., Cho, K.-J., Ahn, C.-H., Byun, Y., et al. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.10.002 · Cited by 119
Self-citationYu, D., Peng, P., Dharap, S. S., Wang, Y., Mehlig, M., Chandna, P., Zhao, H., Filpula, D. R., Yang, K., Borowski, V., et al. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.050 · Cited by 116
Enhanced antitumor effect of camptothecin loaded in long-circulating polymeric micelles
Kawano, K., Watanabe, M., Yamamoto, T., Yokoyama, M., Opanasopit, P., Okano, T., & Maitani, Y. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.03.012 · Cited by 107
Incorporation of camptothecin into N-phthaloyl chitosan-g-mPEG self-assembly micellar system
Opanasopit, P., Ngawhirunpat, T., Chaidedgumjorn, A., Rojanarata, T., Apirakaramwong, A., Phongying, S., Choochottiros, C., & Chirachanchai, S. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.06.001 · Cited by 104
Akimoto, K., KAWAI, A., & Ohya, K. (1994) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.42.2135 · Cited by 63
Cited by
Hydrogel nanoparticles in drug delivery
Hamidi, M., Azadi, A., & Rafiei, P. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.08.002 · Cited by 2,067
Targeted delivery of low molecular drugs using chitosan and its derivatives
Park, J. H., Saravanakumar, G., Kim, K., & Kwon, I. C. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.10.003 · Cited by 821
Self-citationAhmed, T., & Aljaeid, B. (2016) · Drug Design, Development and Therapy · doi:10.2147/dddt.s99651 · Cited by 705
Chitosan as biomaterial in drug delivery and tissue engineering
Ahsan, S. M., Thomas, M., Reddy, K. K., Sooraparaju, S. G., Asthana, A., & Bhatnagar, I. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.08.140 · Cited by 684
Nanotechnology-based drug delivery systems and herbal medicines: a review
Silva, P., Bonifácio, B., Ramos, M., Negri, K., Maria Bauab, T., & Chorilli, M. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s52634 · Cited by 678
Metadata
- Authors
- Min, K. H., Park, K., Kim, Y.-S., Bae, S. M., Lee, S., Jo, H. G., Park, R.-W., Kim, I.-S., Jeong, S. Y., Kim, K., & Kwon, I. C.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2008-05
- Volume
- 127
- Issue
- 3
- Pages
- 208-218
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2087852082
- Cited by
- 460
- References
- 39
- FWCI
- 10.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.